Strategic Global Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172K | Buy |
+10,288
| New | +$172K | 0.03% | 139 |
|
|
2019
Q3 | – | Sell |
-87,712
| Closed | -$810K | – | 163 |
|
|
2019
Q2 | $810K | Sell |
87,712
-535,388
| -86% | -$4.94M | 0.17% | 113 |
|
|
2019
Q1 | $9.77M | Buy |
623,100
+10,504
| +2% | +$165K | 2.06% | 8 |
|
|
2018
Q4 | $9.45M | Buy |
612,596
+269,306
| +78% | +$4.15M | 3.38% | 7 |
|
|
2018
Q3 | $7.39M | Buy |
+343,290
| New | +$7.39M | 2.24% | 9 |
|
|
2017
Q1 | – | Sell |
-6,450
| Closed | -$234K | – | 173 |
|
|
2016
Q4 | $234K | Hold |
6,450
| – | – | 0.09% | 146 |
|
|
2016
Q3 | $323K | Hold |
6,450
| – | – | 0.12% | 133 |
|
|
2016
Q2 | $324K | Hold |
6,450
| – | – | 0.12% | 131 |
|
|
2016
Q1 | $345K | Buy |
6,450
+1,298
| +25% | +$69.4K | 0.15% | 117 |
|
|
2015
Q4 | $338K | Buy |
5,152
+15
| +0.3% | +$984 | 0.14% | 113 |
|
|
2015
Q3 | $290K | Sell |
5,137
-2,918
| -36% | -$165K | 0.14% | 105 |
|
|
2015
Q2 | $476K | Buy |
8,055
+4,519
| +128% | +$267K | 0.28% | 84 |
|
|
2015
Q1 | $220K | Hold |
3,536
| – | – | 0.16% | 123 |
|
|
2014
Q4 | $204K | Buy |
+3,536
| New | +$204K | 0.18% | 127 |
|